Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus: a 2-year follow-up study.
<h4>Objective</h4>Several indices have been proposed to assess disease activity in patients with Systemic Lupus Erythematosus (SLE). Recent studies have showed a prevalence of flare between 28-35.3%, persistently active disease (PAD) between 46%-52% and serologically active clinically qu...
Guardado en:
Autores principales: | Fabrizio Conti, Fulvia Ceccarelli, Carlo Perricone, Francesca Miranda, Simona Truglia, Laura Massaro, Viviana Antonella Pacucci, Virginia Conti, Izabella Bartosiewicz, Francesca Romana Spinelli, Cristiano Alessandri, Guido Valesini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c6bbb231ff840d196225f3e74beb90e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.
por: Fabrizio Conti, et al.
Publicado: (2013) -
Follow-up and management of serologically active clinically
quiescent cases in pediatric systemic lupus erythematosus
por: Gabrielle Capone, et al.
Publicado: (2021) -
Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus
por: Miki Nakano, et al.
Publicado: (2021) -
Peripheral monocyte functions and activation in patients with quiescent Crohn's disease.
por: David Schwarzmaier, et al.
Publicado: (2013) -
Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares--a case control study.
por: Huaxia Yang, et al.
Publicado: (2014)